Ben Charif Ali, Zomahoun Hervé Tchala Vignon, Massougbodji José, Khadhraoui Lobna, Pilon Maxine Dumas, Boulanger Elise, Gogovor Amédé, Campbell Marie-Josée, Poitras Marie-Ève, Légaré France
VITAM - Centre de recherche en santé durable (Ben Charif, Zomahoun, Massougbodji, Khadhraoui, Gogovor, Légaré), Québec, Que.; Tier 1 Canada Research Chair in Shared Decision Making and Knowledge Translation (Ben Charif, Gogovor, Légaré), Université Laval; Health and Social Services Systems, Knowledge Translation and Implementation component of the Quebec SPOR-SUPPORT Unit (Zomahoun, Massougbodji, Khadhraoui, Gogovor), Université Laval; Collège québécois des médecins de famille (Dumas Pilon, Boulanger, Campbell), Laval, Que.; Department of Family Medicine and Emergency Medicine (Poitras), Université de Sherbrooke, Sherbrooke, Que.; Department of Family Medicine and Emergency Medicine (Ben Charif, Légaré), Université Laval, Québec, Que.; Department of Family Medicine (Dumas Pilon) and School of Physical & Occupational Therapy, Faculty of Medicine and Health Sciences (Zomahoun), McGill University, Montréal, Que.
CMAJ Open. 2020 Oct 3;8(4):E613-E618. doi: 10.9778/cmajo.20200030. Print 2020 Oct-Dec.
Canadian health funding currently prioritizes scaling up for evidence-based primary care innovations, but not all teams prepare for scaling up. We explored scalability assessment among primary care innovators in the province of Quebec to evaluate their preparedness for scaling up.
We performed a cross-sectional survey from Feb. 18 to Mar. 18, 2019. Eligible participants were 33 innovation teams selected for the 2019 Quebec College of Family Physicians' Symposium on Innovations. We conducted a Web-based survey in 2 sections: innovation characteristics and the Innovation Scalability Self-administered Questionnaire. The latter includes 16 criteria (scalability components) grouped into 5 dimensions: theory (1 criterion), impact (6 criteria), coverage (4 criteria), setting (3 criteria) and cost (2 criteria). We classified innovation types using the . We performed a descriptive analysis using frequency counts and percentages.
Out of 33 teams, 24 participated (72.7%), with 1 innovation each. The types of innovation were management (15/24), prevention (8/24) and therapeutic (1/24). Most management innovations focused on patient navigation (9/15). In order of frequency, teams had assessed theory (79.2%) and impact (79.2%) criteria, followed by cost (77.1%), setting (59.7%) and coverage (54.2%). Most innovations (16/24) had assessed 10 criteria or more, including 10 management innovations, 5 prevention innovations and 1 therapeutic innovation. Implementation fidelity was the least assessed criterion (6/24).
The scalability assessments of a primary care innovation varied according to its type. Management innovations, which were the most prevalent and assessed the most scalability components, appear to be most prepared for primary care scale-up in Canada.
加拿大的医疗资金目前优先用于扩大基于证据的初级保健创新,但并非所有团队都为扩大规模做好了准备。我们在魁北克省的初级保健创新者中探索了可扩展性评估,以评估他们扩大规模的准备情况。
我们于2019年2月18日至3月18日进行了一项横断面调查。符合条件的参与者是被选参加2019年魁北克家庭医师学院创新研讨会的33个创新团队。我们通过网络进行了一项分为两个部分的调查:创新特征和创新可扩展性自填问卷。后者包括16项标准(可扩展性组成部分),分为5个维度:理论(1项标准)、影响(6项标准)、覆盖范围(4项标准)、环境(3项标准)和成本(2项标准)。我们使用[此处缺失分类依据的具体内容]对创新类型进行分类。我们使用频数和百分比进行描述性分析。
33个团队中有24个参与(72.7%),每个团队有1项创新。创新类型包括管理(15/24)、预防(8/24)和治疗(1/24)。大多数管理创新集中在患者导航方面(9/15)。按频率排序,团队评估了理论(79.2%)和影响(79.2%)标准,其次是成本(77.1%)、环境(59.7%)和覆盖范围(54.2%)。大多数创新(16/24)评估了10项或更多标准,包括10项管理创新、5项预防创新和1项治疗创新。实施保真度是评估最少的标准(6/24)。
初级保健创新的可扩展性评估因其类型而异。管理创新是最普遍的,且评估的可扩展性组成部分最多,似乎在加拿大初级保健扩大规模方面准备最充分。